Rigel Pharmaceuticals Inc. (RIGL) is priced at $1.68 after the most recent trading session. At the very opening of the session, the stock price was $1.55 and reached a high price of $1.72, prior to closing the session it reached the value of $1.61. The stock touched a low price of $1.535.Recently in News on March 7, 2023, Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update. Fourth quarter 2022 Total Revenue of $51.3 million which includes TAVALISSE® net product sales of $21.9 million and REZLIDHIA™ net product sales of $0.9 million. You can read further details here
Rigel Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.5150 on 03/18/22, with the lowest value was $0.6400 for the same time period, recorded on 06/13/22.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Rigel Pharmaceuticals Inc. (RIGL) full year performance was -43.24%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Rigel Pharmaceuticals Inc. shares are logging -52.20% during the 52-week period from high price, and 162.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.64 and $3.52.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4036847 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Rigel Pharmaceuticals Inc. (RIGL) recorded performance in the market was 12.00%, having the revenues showcasing 70.28% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 307.81M, as it employees total of 155 workers.
Rigel Pharmaceuticals Inc. (RIGL) in the eye of market guru’s
During the last month, 0 analysts gave the Rigel Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2684, with a change in the price was noted +0.86. In a similar fashion, Rigel Pharmaceuticals Inc. posted a movement of +105.71% for the period of last 100 days, recording 3,728,705 in trading volumes.
Rigel Pharmaceuticals Inc. (RIGL): Stocks Technical analysis and Trends
Raw Stochastic average of Rigel Pharmaceuticals Inc. in the period of last 50 days is set at 57.65%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.50%. In the last 20 days, the company’s Stochastic %K was 48.33% and its Stochastic %D was recorded 45.00%.
If we look into the earlier routines of Rigel Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 12.00%. Additionally, trading for the stock in the period of the last six months notably improved by 29.23%, alongside a downfall of -43.24% for the period of the last 12 months. The shares increased approximately by -6.15% in the 7-day charts and went down by 3.70% in the period of the last 30 days. Common stock shares were driven by 70.28% during last recorded quarter.